Start/MCK

Public research page

Market data comes from the live feed. The company research below uses verified public sources, but it is not a real-time personalized AI conclusion.

Analyze MCK in workspace
MCKNYSE/health care

McKesson Corporation

$812.28Up+6,32 (+0,78%)
Research reviewed: 12. Juli 2026, 00:00 UTC
Research overview3-month price contextInvestment thesisKey catalystsLatest earnings researchRecent newsData and research sources

Research overview

McKesson Corporation operates in Health Care Distributors within the health care sector. This profile tracks its company-specific earnings drivers, valuation conditions, and primary-source risks.

Eröffnung
812,87
Hoch
822,38
Tief
806,24
Marktkapitalisierung
95,1 Mrd.
KGV
21.18
52-Wochen-Hoch
--
Dividende
0.410%
Quartalsdividende
--

3-month price context

Das Chart zeigt den jüngsten 3-Monats-Trend, damit Nutzer die kurzfristige Struktur verstehen können, bevor sie den vollen Workspace öffnen.

Investment thesis

Base case
Growth in complex medicines can increase distribution, provider-services and data demand. The base case remains conditional on customer concentration staying manageable.
Bull case
Growth in complex medicines can increase distribution, provider-services and data demand. The US Oncology Network and related services can deepen relationships with community practices and manufacturers. Strong cash conversion can fund repurchases and targeted investment in higher-growth health platforms.
Bear case
Large pharmacy and manufacturer relationships can create contract-renewal and pricing leverage risk. Reimbursement, pricing and distribution reforms can alter volumes, working capital and service economics. Controlled-substance obligations and healthcare compliance failures can create litigation and remediation costs.

Key catalysts

  • Specialty distribution

    Growth in complex medicines can increase distribution, provider-services and data demand.

  • Oncology ecosystem

    The US Oncology Network and related services can deepen relationships with community practices and manufacturers.

  • Capital allocation

    Strong cash conversion can fund repurchases and targeted investment in higher-growth health platforms.

Principal risks

  • Customer concentration

    Large pharmacy and manufacturer relationships can create contract-renewal and pricing leverage risk.

  • Drug-policy change

    Reimbursement, pricing and distribution reforms can alter volumes, working capital and service economics.

  • Legal and compliance

    Controlled-substance obligations and healthcare compliance failures can create litigation and remediation costs.

Latest earnings research

FY2026 Q4

McKesson's fiscal fourth-quarter 2026 update reflected resilient pharmaceutical distribution, oncology-platform growth and continued portfolio focus, supported by cash generation and disciplined capital allocation.

Valuation interpretation

  • Distribution scale supports durable cash flow, while oncology and specialty services determine the mix-improvement opportunity.
  • Thin distribution margins require valuation discipline around working capital, customer concentration and policy change.

Peer research

ABBVJNJLLY

Recent news

Zacks · vor 9 Stunden

5 Medical Supply Stocks to Buy Amid Strong Industry Tailwinds

Simply Wall St. · vorgestern

McKesson (MCK) Falls After CEO Share Sale, Is The 14% Discount Enough?

Simply Wall St. · vor 3 Tagen

Can McKesson (MCK) Stay Cheap After A 338% Five Year Run?

Simply Wall St. · vor 3 Tagen

McKesson (MCK) CEO Sells Shares As Company Names A New Strategy Chief

StockStory · vor 4 Tagen

McKesson (MCK) Stock Trades Down, Here Is Why

Continue in the research workspace

Keep MCK in context, run a multi-agent analysis, and monitor thesis changes.

Analyze MCK free

Das gesamte Research-System erkunden

Jede Phase erfüllt eine klare Aufgabe und hinterlässt ein prüfbares Ergebnis.

AnalysemethodikMarktberichte lesen
Thesis invalidation
Reassess the thesis if large pharmacy and manufacturer relationships can create contract-renewal and pricing leverage risk.

Zacks · vor 4 Tagen

Should You Retain CAH Stock After Removal From Several Russell Indices?

Data and research sources

Research updated: 12. Juli 2026, 00:00 UTC
3 verified sources
McKesson Reports Fiscal 2026 Fourth-Quarter ResultsMcKesson Corporation · earningsVerified

Fetched: 12.7.2026, 0:00:00 UTC

Published: 7.5.2026, 00:00:00

Open original source
McKesson Corporation Investor RelationsMcKesson Corporation · companyVerified

Fetched: 12.7.2026, 0:00:00 UTC

Open original source
McKesson SEC filings and company factsU.S. Securities and Exchange Commission · filingVerified

Fetched: 12.7.2026, 0:00:00 UTC

Published: 7.5.2026, 00:00:00

Open original source
Aktien erkunden

Continue researching this stock

Marktanalyst

Marktanalyst fokussiert sich innerhalb von Kernresearch auf die Phase Beobachten und bereitet den Kontext für nachgelagerte Rollen vor.

Fundamentalanalyst

Fundamentalanalyst fokussiert sich innerhalb von Kernresearch auf die Phase Beobachten und bereitet den Kontext für nachgelagerte Rollen vor.

Nachrichtenanalyst

Nachrichtenanalyst fokussiert sich innerhalb von Kernresearch auf die Phase Beobachten und bereitet den Kontext für nachgelagerte Rollen vor.

Risikomanager

Risikomanager fokussiert sich innerhalb von Risiko und Monitoring auf die Phase Überwachen und bereitet den Kontext für nachgelagerte Rollen vor.